Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 62051-62100 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05789758
A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies
N/A
Recruiting
20 participants
Started: Dec 15, 2023 · Completed: Oct 31, 2033
1 condition
1 sponsor
11 locations
NCT06287281
High-heeled Shoes in a Sample of Young Women
N/A
Recruiting
34 participants
Started: Dec 15, 2023 · Completed: Feb 28, 2024
2 conditions
1 sponsor
1 location
NCT06084884
A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma
PHASE1/PHASE2
Active, not recruiting
94 participants
Started: Dec 14, 2023 · Completed: Dec 13, 2027
1 condition
1 sponsor
20 locations
NCT06218394
Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia
NA
Recruiting
135 participants
Started: Dec 14, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05838716
High-Dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients
PHASE3
Recruiting
366 participants
Started: Dec 14, 2023 · Completed: Jul 29, 2032
4 conditions
2 sponsors
46 locations
NCT06312059
Goat or Cow Milk Based Infant Formula GMS
PHASE2/PHASE3
Recruiting
264 participants
Started: Dec 14, 2023 · Completed: Aug 15, 2024
1 condition
2 sponsors
1 location
NCT05817591
Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or Without Allodynia: a Regional Multicenter Prospective Cohort
N/A
Recruiting
400 participants
Started: Dec 14, 2023 · Completed: Jun 15, 2026
1 condition
1 sponsor
10 locations
NCT06165419
Definitive Radiation for High-Risk Spine Metastases
PHASE2
Recruiting
26 participants
Started: Dec 14, 2023 · Completed: May 31, 2026
8 conditions
2 sponsors
1 location
NCT06084338
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
PHASE2
Recruiting
60 participants
Started: Dec 14, 2023 · Completed: Dec 31, 2028
1 condition
1 sponsor
3 locations
NCT06090227
AMPK-activation by Metformin in FSGS: AMP-FSGS
PHASE1/PHASE2
Recruiting
30 participants
Started: Dec 14, 2023 · Completed: Nov 30, 2027
1 condition
2 sponsors
2 locations
NCT06111235
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
PHASE3
Active, not recruiting
367 participants
Started: Dec 14, 2023 · Completed: Jan 31, 2030
4 conditions
1 sponsor
95 locations
NCT06344637
Effects of Cervical Lidocaine Spray on Pain Relief During Manual Vacuum Aspiration
NA
Active, not recruiting
216 participants
Started: Dec 14, 2023 · Completed: Jul 30, 2024
3 conditions
1 sponsor
1 location
NCT06433869
The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites
PHASE2
Recruiting
60 participants
Started: Dec 14, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
3 locations
NCT06537960
Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers
NA
Recruiting
66 participants
Started: Dec 14, 2023 · Completed: Mar 15, 2027
2 conditions
1 sponsor
1 location
NCT06123962
ALI/ARDS Clinical Sub-phenotyping Study
N/A
Recruiting
1,500 participants
Started: Dec 14, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05977907
Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).
PHASE2
Recruiting
15 participants
Started: Dec 14, 2023 · Completed: Oct 16, 2028
1 condition
3 sponsors
5 locations
NCT06137274
Pilot Trial of Adaptive Radiotherapy Boost for HNSCC
NA
Active, not recruiting
25 participants
Started: Dec 14, 2023 · Completed: Nov 30, 2026
2 conditions
1 sponsor
1 location
NCT06168604
Evaluating the Efficacy of the Pain Identification and Communication Toolkit
NA
Recruiting
440 participants
Started: Dec 14, 2023 · Completed: Feb 29, 2028
5 conditions
2 sponsors
1 location
NCT06099730
Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
NA
Active, not recruiting
360 participants
Started: Dec 14, 2023 · Completed: Nov 30, 2026
1 condition
1 sponsor
7 locations
NCT05890365
Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
N/A
Recruiting
300 participants
Started: Dec 14, 2023 · Completed: Aug 31, 2025
2 conditions
3 sponsors
1 location
NCT06135324
Impairments That Affect Correct Inhaler Use in COPD
N/A
Active, not recruiting
500 participants
Started: Dec 14, 2023 · Completed: Oct 31, 2025
1 condition
2 sponsors
9 locations
NCT06965075
The SCULPT-Job Cohort Study
NA
Active, not recruiting
15 participants
Started: Dec 14, 2023 · Completed: Jun 30, 2025
8 conditions
2 sponsors
1 location
NCT05599490
Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB
NA
Active, not recruiting
180 participants
Started: Dec 14, 2023 · Completed: Apr 1, 2026
1 condition
3 sponsors
2 locations
NCT06154356
Action Observation and Motor Imagery Therapy in Parkinson's Disease
NA
Recruiting
54 participants
Started: Dec 14, 2023 · Completed: Dec 30, 2024
1 condition
2 sponsors
1 location
NCT06146790
Evaluation of Endovascular Treatment in Acute Intracranial Distal Medium Vessel Occlusion Stroke
NA
Recruiting
564 participants
Started: Dec 14, 2023 · Completed: Mar 1, 2026
2 conditions
1 sponsor
1 location
NCT05946213
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
PHASE3
Recruiting
1,209 participants
Started: Dec 14, 2023 · Completed: Mar 31, 2036
3 conditions
1 sponsor
345 locations
NCT05922904
PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
PHASE2
Active, not recruiting
25 participants
Started: Dec 14, 2023 · Completed: Oct 30, 2027
1 condition
3 sponsors
1 location
NCT06178614
A Study of JNJ-87890387 for Advanced Solid Tumors
PHASE1
Recruiting
200 participants
Started: Dec 14, 2023 · Completed: Jul 21, 2028
1 condition
1 sponsor
6 locations
NCT05286827
Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma
PHASE2
Active, not recruiting
20 participants
Started: Dec 14, 2023 · Completed: Dec 18, 2025
1 condition
1 sponsor
1 location
NCT06708208
Requests for Voluntary Termination and Medical Termination of Pregnancy for Maternal, Psychological or Social Reasons At the Women's Center ( La Maison Des Femmes) in Saint-Denis :
N/A
Active, not recruiting
107 participants
Started: Dec 14, 2023 · Completed: Dec 20, 2024
7 conditions
1 sponsor
1 location
NCT05175885
Ex Vivo Normothermic Perfusion in Kidney Transplantation.
NA
Recruiting
100 participants
Started: Dec 14, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06572215
DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve
N/A
Recruiting
44 participants
Started: Dec 14, 2023 · Completed: Jan 1, 2025
1 condition
2 sponsors
1 location
NCT05761015
Helping Osteoarthritis Patients to Walk With NSAID
PHASE4
Recruiting
55 participants
Started: Dec 14, 2023 · Completed: Nov 1, 2025
3 conditions
10 sponsors
1 location
NCT06132880
Effects of Human Urinary Kallidinogenase on Early Improvement and Functional Outcomes in Acute Ischemic Stroke (TK-SPEED)
NA
Not yet recruiting
540 participants
Started: Dec 14, 2023 · Completed: Dec 31, 2026
2 conditions
2 sponsors
0 locations
NCT06204172
Intensive Neurowave Emotional Stimulation (INES)
NA
Recruiting
40 participants
Started: Dec 14, 2023 · Completed: Sep 15, 2025
1 condition
1 sponsor
1 location
NCT06214858
The Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects
PHASE1
Recruiting
76 participants
Started: Dec 14, 2023 · Completed: Apr 30, 2024
1 condition
1 sponsor
1 location
NCT05946824
This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.
PHASE2
Recruiting
80 participants
Started: Dec 14, 2023 · Completed: Nov 24, 2028
1 condition
2 sponsors
1 location
NCT05560659
Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
PHASE2
Recruiting
92 participants
Started: Dec 14, 2023 · Completed: May 31, 2027
1 condition
2 sponsors
3 locations
NCT04981730
The Development and Evaluation of a Web-based Childbirth and Parenting Intervention Program
NA
Recruiting
600 participants
Started: Dec 14, 2023 · Completed: Oct 14, 2025
3 conditions
1 sponsor
1 location
NCT06149819
Chest Pain Nurse Track
NA
Recruiting
182 participants
Started: Dec 14, 2023 · Completed: Dec 20, 2025
1 condition
1 sponsor
1 location
NCT05981911
Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice
N/A
Recruiting
2,000 participants
Started: Dec 14, 2023 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT06129864
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
PHASE3
Recruiting
1,145 participants
Started: Dec 14, 2023 · Completed: Sep 12, 2030
1 condition
1 sponsor
294 locations
NCT06082635
TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)
PHASE3
Active, not recruiting
321 participants
Started: Dec 14, 2023 · Completed: Nov 30, 2028
1 condition
2 sponsors
1 location
NCT05929222
Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi
PHASE3
Recruiting
190 participants
Started: Dec 14, 2023 · Completed: Apr 30, 2031
1 condition
1 sponsor
48 locations
NCT05231629
Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
PHASE2
Recruiting
300 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2027
1 condition
3 sponsors
10 locations
NCT06407271
Effect of Abutment Configuration on Peri-implant Soft and Hard Tissue in the Esthetic Zone - Randomized Clinical Trial
NA
Recruiting
30 participants
Started: Dec 13, 2023 · Completed: Dec 30, 2028
2 conditions
2 sponsors
1 location
NCT06112106
The Effect of Intelligent Exercise and Ergonomic Recommendations on Surgeon Musculoskeletal Discomfort
NA
Enrolling by invitation
170 participants
Started: Dec 13, 2023 · Completed: Jun 1, 2026
2 conditions
2 sponsors
7 locations
NCT05554367
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
PHASE2
Active, not recruiting
199 participants
Started: Dec 13, 2023 · Completed: Aug 26, 2026
5 conditions
1 sponsor
267 locations
NCT06183268
Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy
NA
Recruiting
100 participants
Started: Dec 13, 2023 · Completed: Jan 2, 2030
3 conditions
1 sponsor
1 location
NCT06295302
A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria
PHASE2
Recruiting
120 participants
Started: Dec 13, 2023 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
1239
1240
1241
1242
1243
1244
1245
More pages
2369
Next